Serum lipids and Lp-PLA2 activity in multiple sclerosis

---

Atıf İçin Kopyala

Dogan H. O., Yilmaz F. M., Uysal S., Mungan S., Ak F.

Turkish Journal of Biochemistry-Turk Biyokimya Dergisi, cilt.39, sa.4, ss.472-475, 2014 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 39 Sayı: 4
• Basım Tarihi: 2014
• Doi Numarası: 10.5505/tjb.2014.27147
• Dergi Adı: Turkish Journal of Biochemistry-Turk Biyokimya Dergisi
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.472-475
• Sivas Cumhuriyet Üniversitesi Adresli: Hayır

Özet

Objective: Multiple sclerosis (MS) is an inflammatory demyelinating disease arising from unknown origin. Dyslipidemia, T-lymphocyte mediated inflammation, lipoprotein associated oxidative activity and lipoprotein associated phospholipase A2 (Lp-PLA2) activity include the pathogenesis of MS. In the current study, we evaluated the effect of Lp-PLA2 activity and serum lipids in MS patients with different clinical stages to understand the effect these parameters on MS progression.